首页> 美国卫生研究院文献>Cancer Medicine >Inhibition of telomerase activity and induction of apoptosis by Rhodospirillum rubrum l‐asparaginase in cancer Jurkat cell line and normal human CD4+ T lymphocytes
【2h】

Inhibition of telomerase activity and induction of apoptosis by Rhodospirillum rubrum l‐asparaginase in cancer Jurkat cell line and normal human CD4+ T lymphocytes

机译:红螺螺旋藻抑制端粒酶活性并诱导细胞凋亡癌症Jurkat细胞系和正常人CD4 + T淋巴细胞中的l-天冬酰胺酶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Rhodospirillum rubrum L‐asparaginase mutant E149R, V150P, F151T (RrA) down‐regulates telomerase activity due to its ability to inhibit the expression of telomerase catalytic subunit hTERT. The aim of this study was to define the effect of short‐term and long‐term RrA exposure on proliferation of cancer Jurkat cell line and normal human CD4+ T lymphocytes. RrA could inhibit telomerase activity in dose‐ and time‐dependent manner in both Jurkat and normal CD4+ T cells. Continuous RrA exposure of these cells resulted in shortening of telomeres followed by cell cycle inhibition, replicative senescence, and development of apoptosis. Complete death of Jurkat cells was observed at the day 25 of RrA exposure while normal CD4+ T cells died at the day 50 due to the initial longer length of telomeres. Removal of RrA from senescent cells led to a reactivation of hTERT expression, restoration telomerase activity, re‐elongation of telomeres after 48 h of cultivation, and survival of cells. These findings demonstrate that proliferation of cancer and normal telomerase‐positive cells can be limited by continuous telomerase inhibition with RrA. Longer telomeres of normal CD4+ T lymphocytes make such cells more sustainable to RrA exposure that could give them an advantage during anti‐telomerase therapy. These results should facilitate further investigations of RrA as a potent anti‐telomerase therapeutic protein.
机译:红螺螺旋藻L-天冬酰胺酶突变体E149R,V150P,F151T(RrA)由于具有抑制端粒酶催化亚基hTERT表达的能力而下调了端粒酶活性。这项研究的目的是确定短期和长期暴露于RrA对癌症Jurkat细胞系和正常人CD4 + T淋巴细胞增殖的影响。 RrA可以在Jurkat和正常CD4 + T细胞中以剂量和时间依赖性方式抑制端粒酶活性。这些细胞的连续RrA暴露导致端粒缩短,随后是细胞周期抑制,复制性衰老和凋亡的发展。在暴露于RrA的第25天,观察到Jurkat细胞完全死亡,而正常的CD4 + T细胞在第50天由于端粒初始较长而死亡。从衰老细胞中去除RrA会导致hTERT表达重新激活,端粒酶活性恢复,培养48小时后端粒重新伸长以及细胞存活。这些发现表明,RrA持续抑制端粒酶可限制癌细胞和端粒酶阳性细胞的增殖。正常CD4 + T淋巴细胞的端粒更长,使此类细胞对RrA暴露更具可持续性,这可能使其在抗端粒酶治疗中具有优势。这些结果应有助于进一步研究RrA作为有效的抗端粒酶治疗蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号